자궁내막증 치료 시장 규모, 점유율 및 성장 분석 : 약물 요법별, 외과적 치료별, 대체요법별, 진단법별, 지역별 - 업계 예측(2026-2033년)

Global Endometriosis Treatment Market size was valued at USD 2.3 Billion in 2024 and is poised to grow from USD 2.43 Billion in 2025 to USD 3.72 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The global endometriosis treatment market is witnessing significant growth due to heightened awareness and advancements in diagnostic technologies, which enhance detection of this chronic gynecological condition characterized by endometrial-like tissue growth outside the uterus. This surge in diagnosed cases is elevating demand for pharmaceuticals, surgical devices, and specialized services. The evolution of management strategies from invasive procedures to minimally invasive techniques and biologics has broadened treatment options, fostering innovation and attracting investments. Key drivers include enhanced diagnostics and targeted therapies, enabling earlier detection and personalized treatment plans that improve patient outcomes and reduce costs. Additionally, the integration of AI in diagnostics, through advanced imaging and pattern recognition, is enabling more accurate and timely interventions, thus creating commercial opportunities across various areas of the market, including telehealth and personalized care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endometriosis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endometriosis Treatment Market Segments Analysis

Global endometriosis treatment market is segmented by pharmaceutical treatments, surgical treatments, alternative treatments, diagnostic methods and region. Based on pharmaceutical treatments, the market is segmented into Hormonal Therapies and Pain Management. Based on surgical treatments, the market is segmented into Laparoscopic Surgery and Hysterectomy Procedures. Based on alternative treatments, the market is segmented into Dietary Supplements and Physical Therapy. Based on diagnostic methods, the market is segmented into Imaging Techniques and Laparoscopy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endometriosis Treatment Market

The increasing awareness of endometriosis among both the public and healthcare professionals is significantly enhancing the identification of symptoms, leading to a larger number of women seeking medical assistance. This heightened awareness not only expands the pool of patients utilizing treatment options but also encourages healthcare providers to make earlier referrals and adopt standardized diagnostic methods. Consequently, pharmaceutical and device manufacturers are motivated to prioritize the creation of targeted therapies. This growing demand spurs investments in various treatment options and supportive care programs, strengthens patient advocacy influence in research, and sustains positive momentum in the market through broader adoption of treatment solutions and long-term care strategies.

Restraints in the Global Endometriosis Treatment Market

The Global Endometriosis Treatment market faces significant constraints due to uneven access to specialized diagnostic services and inconsistencies in clinical recognition, which hinder the timely diagnosis of endometriosis. This results in fewer patients pursuing formal treatment options, thereby diminishing the demand for innovative therapies. Geographic disparities, a shortage of trained specialists, and sociocultural obstacles to accessing care further exacerbate the underrepresentation of potential patients in clinical environments, which ultimately narrows the perceived market opportunities. Such limitations in visibility inhibit motivation for widespread commercialization and focused distribution, consequently impeding investments in product deployment and restricting scalability of treatment programs across varied healthcare systems.

Market Trends of the Global Endometriosis Treatment Market

The Global Endometriosis Treatment market is experiencing a significant trend toward the adoption of digital therapeutics, which is transforming the landscape of endometriosis management. The integration of remote monitoring and health technology platforms is enhancing patient engagement by facilitating continuous symptom tracking and personalized care pathways. This evolution is fostering collaboration among biopharma, medtech, and software developers to expedite innovative solution development while encouraging reimbursement discussions. Such digital tools not only complement traditional pharmacologic and surgical interventions but also support remote consultations, enabling scalable, long-term disease management focused on patient-centered outcomes and effective care coordination.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Endometriosis Treatment Market Size by Pharmaceutical Treatments & CAGR (2026-2033)

• Market Overview
• Hormonal Therapies
  • Birth Control Pills
  • GnRH Agonists
• Pain Management
  • Non-steroidal Anti-inflammatory Drugs
  • Opioid Medications

Global Endometriosis Treatment Market Size by Surgical Treatments & CAGR (2026-2033)

• Market Overview
• Laparoscopic Surgery
  • Lysis of Adhesions
  • Endometrioma Removal
• Hysterectomy Procedures
  • Total Hysterectomy
  • Partial Hysterectomy

Global Endometriosis Treatment Market Size by Alternative Treatments & CAGR (2026-2033)

• Market Overview
• Dietary Supplements
  • Omega-3 Fatty Acids
  • Vitamin D
• Physical Therapy
  • Pelvic Floor Therapy
  • Acupuncture

Global Endometriosis Treatment Market Size by Diagnostic Methods & CAGR (2026-2033)

• Market Overview
• Imaging Techniques
  • Ultrasound
  • MRI Scans
• Laparoscopy
  • Diagnostic Laparoscopy
  • Therapeutic Laparoscopy

Global Endometriosis Treatment Market Size & CAGR (2026-2033)

• North America (Pharmaceutical Treatments, Surgical Treatments, Alternative Treatments, Diagnostic Methods)
  • US
  • Canada
• Europe (Pharmaceutical Treatments, Surgical Treatments, Alternative Treatments, Diagnostic Methods)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Pharmaceutical Treatments, Surgical Treatments, Alternative Treatments, Diagnostic Methods)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Pharmaceutical Treatments, Surgical Treatments, Alternative Treatments, Diagnostic Methods)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Pharmaceutical Treatments, Surgical Treatments, Alternative Treatments, Diagnostic Methods)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myovant Sciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymeworks Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Priothera
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endometriosis Foundation of America
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karyopharm Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Therapeutics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incyte Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gedeon Richter Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorrento Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Impaxis Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTL Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Serono
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solvay S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations